Clinical trial NCT01607671 - References

Ischemic Optic Neuropathy — Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

Citation(s)

•   Atkins EJ, Bruce BB, Newman NJ, Biousse V
  Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010 Jan-Feb;55(1):47-63. doi: 10.1016/j.survophthal.2009.06.008. Review.
•   Glucksberg MR, Dunn R
  Direct measurement of retinal microvascular pressures in the live, anesthetized cat. Microvasc Res. 1993 Mar;45(2):158-65.
•   Mäepea O
  Pressures in the anterior ciliary arteries, choroidal veins and choriocapillaris. Exp Eye Res. 1992 May;54(5):731-6.
•   Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful
  The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA. 1995 Feb 22;273(8):625-32.
•   Wilhelm B, Lüdtke H, Wilhelm H; BRAION Study Group
  Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):551-8. Epub 2005 Sep 8.

Can Urgent Reduction of Intraocular Pressure With Ophthalmic Timolol Improve Recovery From Non-arteritic Anterior Ischemic Optic Neuropathy (NAION): a Randomized Study.

Details for clinical trial NCT01607671